SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-23-025153
Filing Date
2023-07-20
Accepted
2023-07-20 21:57:30
Documents
1
Period of Report
2023-06-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2347
  Complete submission text file 0001493152-23-025153.txt   3742
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NO. 23 LORONG TERUBONG RIA 2, PAYA TERUBONG GEORGE TOWN N8 11060
Business Address
Choong Choon Hau (Reporting) CIK: 0001986021 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13341 | Film No.: 231100998